Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective - PubMed (original) (raw)
. 2004 Feb 6;279(6):4625-31.
doi: 10.1074/jbc.M310994200. Epub 2003 Nov 19.
Affiliations
- PMID: 14627698
- DOI: 10.1074/jbc.M310994200
Free article
Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective
Mikiei Tanaka et al. J Biol Chem. 2004.
Free article
Abstract
Lewy bodies (LBs), which are the hallmark pathologic features of Parkinson's disease and of dementia with LBs, have several morphologic and molecular similarities to aggresomes. Whether such cytoplasmic inclusions contribute to neuronal death or protect cells from the toxic effects of misfolded proteins remains controversial. In this report, the role of aggresomes in cell viability was addressed in the context of over-expressing alpha-synuclein and its interacting partner synphilin-1 using engineered 293T cells. Inhibition of proteasome activity elicited the formation of juxtanuclear aggregates with characteristics of aggresomes including immunoreactivity for vimentin, gamma-tubulin, ubiquitin, proteasome subunit, and hsp70. As expected from the properties of aggresomes, the microtubule disrupting agents, vinblastin and nocodazole, markedly prevented the formation of these inclusions. Similar to LBs, the phosphorylated form of alpha-synuclein co-localized in these synphilin-1-containing aggresomes. Although the caspase inhibitor z-VAD-fmk significantly reduced the number of apoptotic cells, it had no impact on the percentage of aggresome-positive cells. Finally, quantitative analysis revealed aggresomes in 60% of nonapoptotic cells but only in 10% of apoptotic cells. Additionally, alpha-synuclein-induced apoptosis was not coupled with increased prevalence of aggresome-bearing cells. Taken together, these observations indicate a disconnection between aggresome formation and apoptosis, and support a protective role for these inclusions from the toxicity associated with the combined over-expression of alpha-synuclein and synphilin-1.
Similar articles
- UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA. Ardley HC, et al. J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595 - Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S. Liani E, et al. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5500-5. doi: 10.1073/pnas.0401081101. Epub 2004 Apr 2. Proc Natl Acad Sci U S A. 2004. PMID: 15064394 Free PMC article. - Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G, Junn E, Tanaka M, Kim YM, Mouradian MM. Lee G, et al. J Neurochem. 2002 Oct;83(2):346-52. doi: 10.1046/j.1471-4159.2002.01136.x. J Neurochem. 2002. PMID: 12423244 - Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A, Engelender S. Eyal A, et al. Cell Cycle. 2006 Sep;5(18):2082-6. doi: 10.4161/cc.5.18.3209. Epub 2006 Sep 15. Cell Cycle. 2006. PMID: 16969096 Review. - [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K, Takahashi H. Wakabayashi K, et al. Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
Cited by
- Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions.
Bayati A, McPherson PS. Bayati A, et al. J Biol Chem. 2024 Sep 2;300(10):107742. doi: 10.1016/j.jbc.2024.107742. Online ahead of print. J Biol Chem. 2024. PMID: 39233232 Free PMC article. Review. - Intranasal administration of trehalose reduces α-synuclein oligomers and accelerates α-synuclein aggregation.
Tanaka MT, Miki Y, Mori F, Kon T, Furukawa T, Shimoyama S, Tatara Y, Ozaki T, Bettencourt C, Warner TT, Wakabayashi K. Tanaka MT, et al. Brain Commun. 2024 Aug 20;6(4):fcae193. doi: 10.1093/braincomms/fcae193. eCollection 2024. Brain Commun. 2024. PMID: 39165481 Free PMC article. - Parkinson's disease is associated with low striated esophagus contractility potentially contributing to the development of dysphagia.
Kerschner A, Hassan H, Kern M, Edeani F, Mei L, Sanvanson P, Shaker R, Yu E. Kerschner A, et al. Neurogastroenterol Motil. 2024 Aug;36(8):e14822. doi: 10.1111/nmo.14822. Epub 2024 May 26. Neurogastroenterol Motil. 2024. PMID: 38798058 - Genetic modifiers of synucleinopathies-lessons from experimental models.
Lee RMQ, Koh TW. Lee RMQ, et al. Oxf Open Neurosci. 2023 Mar 9;2:kvad001. doi: 10.1093/oons/kvad001. eCollection 2023. Oxf Open Neurosci. 2023. PMID: 38596238 Free PMC article. Review. - Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment.
Berthenet K, Aïmontché E, El Mrini S, Brière J, Pion N, Iacono I, Brejon S, Monier K, Catez F, Ichim G, Combaret V, Mertani HC, Diaz JJ, Albaret MA. Berthenet K, et al. Sci Rep. 2024 Feb 14;14(1):3768. doi: 10.1038/s41598-024-54140-7. Sci Rep. 2024. PMID: 38355966 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous